Viridian Therapeutics, Inc.DE (VRDN) stock
VRDNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 4/30260% above fair value
$29.96−1.48 (-4.71%)
Close on Nov 20, 2026Market cap $3.39BP/E –Yield –
Viridian Therapeutics, Inc.DE market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Viridian Therapeutics, Inc.DE's market cap was $3.54B on Nov 11, 2026, against $2.63B a year earlier. Over the last 5 years it ranged from $276.80M to $3.54B, with a median of $1.10B.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $3.54B | +38.3% |
| 2025 | Dec 31, 2025 | $2.56B | +68.6% |
| 2024 | Dec 31, 2024 | $1.52B | +59.5% |
| 2023 | Dec 29, 2023 | $951.81M | -19.0% |
| 2022 | Dec 30, 2022 | $1.18B | +206.9% |
| 2021 | Dec 31, 2021 | $383.08M | +512.0% |
| 2020 | Dec 31, 2020 | $62.59M | +318.3% |
| 2019 | Dec 31, 2019 | $14.96M | -84.0% |
| 2018 | Dec 31, 2018 | $93.42M | -59.1% |
| 2017 | Dec 29, 2017 | $228.27M | +6234.0% |
| 2016 | Dec 30, 2016 | $3.60M | -54.7% |
| 2015 | Dec 31, 2015 | $7.96M | +976.6% |
| 2014 | Dec 31, 2014 | $738.95K | – |
See a number that looks wrong?